- Home
- PEN vs CHH Comparison
PEN vs CHH Comparison
Compare PEN & CHH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PEN
- CHH
- Stock Information
- Founded
- PEN 2004
- CHH 1939
- Country
- PEN United States
- CHH United States
- Employees
- PEN N/A
- CHH N/A
- Industry
- PEN Medical/Dental Instruments
- CHH Hotels/Resorts
- Sector
- PEN Health Care
- CHH Consumer Discretionary
- Exchange
- PEN Nasdaq
- CHH Nasdaq
- Market Cap
- PEN 9.1B
- CHH 6.8B
- IPO Year
- PEN 2015
- CHH 1997
- Fundamental
- Price
- PEN $241.10
- CHH $142.66
- Analyst Decision
- PEN Buy
- CHH Sell
- Analyst Count
- PEN 15
- CHH 12
- Target Price
- PEN $259.86
- CHH $132.92
- AVG Volume (30 Days)
- PEN 316.9K
- CHH 253.1K
- Earning Date
- PEN 02-20-2025
- CHH 02-18-2025
- Dividend Yield
- PEN N/A
- CHH 0.81%
- EPS Growth
- PEN N/A
- CHH N/A
- EPS
- PEN 0.89
- CHH 5.17
- Revenue
- PEN $1,163,776,000.00
- CHH $779,010,000.00
- Revenue This Year
- PEN $13.55
- CHH $108.95
- Revenue Next Year
- PEN $14.48
- CHH $3.15
- P/E Ratio
- PEN $268.19
- CHH $27.45
- Revenue Growth
- PEN 16.96
- CHH 3.06
- 52 Week Low
- PEN $148.00
- CHH $108.91
- 52 Week High
- PEN $277.34
- CHH $153.81
- Technical
- Relative Strength Index (RSI)
- PEN 52.20
- CHH 42.96
- Support Level
- PEN $234.55
- CHH $138.29
- Resistance Level
- PEN $241.89
- CHH $142.39
- Average True Range (ATR)
- PEN 6.40
- CHH 2.83
- MACD
- PEN -1.31
- CHH -0.38
- Stochastic Oscillator
- PEN 36.55
- CHH 29.27
About PEN Penumbra Inc.
Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. The neurovascular product category contributes to the majority of revenue. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. Penumbra generates the majority of its revenue in the United States.
About CHH Choice Hotels International Inc.
As of Dec. 31, 2023, Choice Hotels operated 633,000 rooms across 15 brands addressing the economy and midscale segments. Comfort Inn and Comfort Suites are the largest brands (27% of the company's total domestic rooms), while Ascend and Cambria (7% of total domestic rooms) are newer lifestyle and select-service brands. Choice closed on its Radisson acquisition in August 2022, which added around 70,000 rooms. Franchises account for 100% of total revenue, and the United States represent 79% of total rooms in 2023.